Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1078155220924084 http://scihub22266oqcxt.onion/10.1177/1078155220924084 32423324!ä!32423324 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Oncol+Pharm+Pract 2020 ; 26 (5): 1289-1294 Nephropedia Template TP {{tp|p=32423324|t=2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab |pdf=|usr=}}{{32423324}} gab.com Text Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab JO: J Oncol Pharm Pract http://www.kidney.de/pget.php?&tw=1&pmid=32423324 #FOAvip Outbreak of the new type coronavirus infection, known as coronavirus infection 2019 (COVID-19), has begun in December 2019, in Wuhan, China. As of today, 3 April 2020, 972,640 people affected and 50,325 people died from Severe Acute Respiratory Syndrome-Coronavirus 2. There is not any standard treatment for coronavirus infection 2019; however, there are promising data for hydroxychloroquine and some anti-retroviral drugs. Programmed death-1 (PD-1)/programmed death ligand-1 (PDL-1) pathway is an important target for the cancer immunotherapy. However, there is a robust pre-clinical and clinical data regarding inhibitor effect of this pathway on the acute or chronic viral infections. Thus, blockade of this pathway may lead to an anti-viral effect and decrease viral load. Here, we report the clinical course of coronavirus infection 2019 infection of a patient in whom older aged, having multiple co-morbidities, and taking nivolumab for metastatic malignant melanoma. In contrast to her older age, comorbidities, and cancer diagnosis, she was in a good condition, and there was also no pneumonia finding. We think that this good clinical course of coronavirus infection 2019 infection may be related to blockade of PD-1/PDL-1 pathway with nivolumab. It is impossible to say that blockade of PD-1/PDL-1pathway is a treatment option for COVID-19; however, we want to share our experience. Twit Text FOAVip Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab ????J Oncol Pharm Pract http://www.kidney.de/pget.php?&tw=1&pmid=32423324 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32423324 #FOAvip English Wikipedia <ref>{{Cite pmid|32423324}}</ref> Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab #MMPMID32423324 Yekeduz E; Dursun B; Aydin GC; Yazgan SC; Ozturk HH; Azap A; Utkan G; Urun Y J Oncol Pharm Pract 2020[Jul]; 26 (5): 1289-1294 PMID32423324show ga Outbreak of the new type coronavirus infection, known as coronavirus infection 2019 (COVID-19), has begun in December 2019, in Wuhan, China. As of today, 3 April 2020, 972,640 people affected and 50,325 people died from Severe Acute Respiratory Syndrome-Coronavirus 2. There is not any standard treatment for coronavirus infection 2019; however, there are promising data for hydroxychloroquine and some anti-retroviral drugs. Programmed death-1 (PD-1)/programmed death ligand-1 (PDL-1) pathway is an important target for the cancer immunotherapy. However, there is a robust pre-clinical and clinical data regarding inhibitor effect of this pathway on the acute or chronic viral infections. Thus, blockade of this pathway may lead to an anti-viral effect and decrease viral load. Here, we report the clinical course of coronavirus infection 2019 infection of a patient in whom older aged, having multiple co-morbidities, and taking nivolumab for metastatic malignant melanoma. In contrast to her older age, comorbidities, and cancer diagnosis, she was in a good condition, and there was also no pneumonia finding. We think that this good clinical course of coronavirus infection 2019 infection may be related to blockade of PD-1/PDL-1 pathway with nivolumab. It is impossible to say that blockade of PD-1/PDL-1pathway is a treatment option for COVID-19; however, we want to share our experience. |*Betacoronavirus/drug effects/physiology[MESH] |*Coronavirus Infections/diagnosis/epidemiology/physiopathology/virology[MESH] |*Lung Neoplasms/drug therapy/secondary[MESH] |*Melanoma/drug therapy/epidemiology/pathology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/epidemiology/physiopathology/virology[MESH] |Aged[MESH] |Antineoplastic Agents, Immunological/administration & dosage/immunology[MESH] |Antiviral Agents/administration & dosage[MESH] |Azithromycin/*administration & dosage[MESH] |COVID-19[MESH] |Female[MESH] |Humans[MESH] |Hydroxychloroquine/administration & dosage[MESH] |Multiple Chronic Conditions/epidemiology[MESH] |Nivolumab/*administration & dosage/immunology[MESH] |Oseltamivir/*administration & dosage[MESH] |Programmed Cell Death 1 Receptor/antagonists & inhibitors[MESH] |SARS-CoV-2[MESH] |Tomography, X-Ray Computed/methods[MESH]Clinical course of COVID-19 infection in elderly patient with melanoma(epmc).pdf DeepDyve Pubget Overpricing